Drawing for AMABEL

USPTO serial 86662342

AMABEL

Reviewed by CopyMark Law Group

Reg. 5409871Status 710
Filing date
Status date
Registration date
Feb 27, 2018
Examiner
SOUDERS, MICHAEL J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with AMABEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietetic foods adapted for medical use, namely, protein supplement shakes, protein bars in the nature of dietary supplements, plant based protein dietary supplements, nutritional supplement drinks for weight loss drinks made from natural ingredients, not including any pharmaceutical preparations and substances or pharmaceutical preparations and substances for the oral treatment of diabetes in humans, and vaccines; dietetic sugar for medical use not including any pharmaceutical preparations and substances or pharmaceutical preparations and substances for the oral treatment of diabetes in humans; dietary supplements not including any pharmaceutical preparations and substances or pharmaceutical preparations and substances for the oral treatment of diabetes in humans; herbal dietary supplements not including any pharmaceutical preparations and substances or pharmaceutical preparations and substances for the oral treatment of diabetes in humansSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2024C8..CANCELLED SEC. 8 (6-YR)
Feb 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NPUBNOTICE OF PUBLICATION
Nov 3, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 13, 2017CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
May 23, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
May 9, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
May 1, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 24, 2016CNSIINQUIRY AS TO SUSPENSION MAILED
Oct 24, 2016CNSISUSPENSION INQUIRY WRITTEN
Oct 21, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 19, 2016CNSLLETTER OF SUSPENSION MAILED
Apr 18, 2016CNSLSUSPENSION LETTER WRITTEN
Apr 18, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2016ALIEASSIGNED TO LIE
Mar 25, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2015CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2015DOCKASSIGNED TO EXAMINER
Jun 18, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2015NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance